DrugPatentWatch Database Preview
Validus Pharms Company Profile
» See Plans and Pricing
What is the competitive landscape for VALIDUS PHARMS, and what generic alternatives to VALIDUS PHARMS drugs are available?
VALIDUS PHARMS has six approved drugs.
There is one US patent protecting VALIDUS PHARMS drugs.
There is one patent family member on VALIDUS PHARMS drugs in one country.
Summary for Validus Pharms
| International Patents: | 1 |
| US Patents: | 1 |
| Tradenames: | 4 |
| Ingredients: | 4 |
| NDAs: | 6 |
Drugs and US Patents for Validus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Validus Pharms | BUMEX | bumetanide | TABLET;ORAL | 018225-003 | Jun 14, 1985 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
| Validus Pharms Inc | MARPLAN | isocarboxazid | TABLET;ORAL | 011961-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-002 | Dec 10, 2004 | RX | Yes | No | 6,977,253 | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Validus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Validus Pharms | ROCALTROL | calcitriol | CAPSULE;ORAL | 018044-002 | Approved Prior to Jan 1, 1982 | 4,391,802 | Start Trial |
| Validus Pharms | ROCALTROL | calcitriol | CAPSULE;ORAL | 018044-002 | Approved Prior to Jan 1, 1982 | 4,225,596 | Start Trial |
| Validus Pharms | EQUETRO | carbamazepine | CAPSULE, EXTENDED RELEASE;ORAL | 021710-003 | Dec 10, 2004 | 5,912,013 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VALIDUS PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 100 mg | ➤ Subscribe | 2014-05-23 |
| ➤ Subscribe | Extended-release Capsules | 200 mg and 300 mg | ➤ Subscribe | 2007-08-21 |
International Patents for Validus Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Canada | 2452588 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
